Opportunity
DIBBS #SPE2DP-27-T-0308
DLA procurement of atenolol 25 mg tablets
Posted
November 13, 2026
Respond By
November 18, 2026
Identifier
SPE2DP-27-T-0308
NAICS
424210, 325412
DLA Troop Support is seeking a small quantity of generic atenolol tablets for Army destinations. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; buyer contact: Imerah Burnett. - Product: Atenolol tablets, 25 mg, in 100-count bottles (NSN 6505-01-336-6196); 1 bottle contains 100 tablets. - CLIN 1: 2 bottles. - CLIN 2: 1 bottle. - Approved sources and listed part numbers: Mylan Pharmaceuticals Inc. (NDC00378-0218-01), McKesson Corporation (463649), and Teva Pharmaceuticals USA, Inc. (NDC00093-0787-01). - Requirements: FDA-regulated drug, minimum 36-month non-extendable shelf life, and delivery within 20 days after order to separate Army destinations.
Description
ATENOLOL TABLETS (QTY: 1, NSN: 6505-01-336-6196, Purchase Request: 7019117035) Approved Sources: - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.
ATENOLOL TABLETS (QTY: 2, NSN: 6505-01-336-6196, Purchase Request: 7019092000) Approved Sources: - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.